Head to Head Survey: IDEXX Laboratories (NASDAQ:IDXX) vs. Vicarious Surgical (NYSE:RBOT)

IDEXX Laboratories (NASDAQ:IDXX) and Vicarious Surgical (NYSE:RBOT) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, earnings, analyst recommendations, valuation, dividends and institutional ownership.

Analyst Ratings

This is a summary of current recommendations and price targets for IDEXX Laboratories and Vicarious Surgical, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IDEXX Laboratories	0	4	7	0	2.64
Vicarious Surgical	1	2	0	0	1.67

IDEXX Laboratories currently has a consensus target price of $751.00, suggesting a potential upside of 32.21%. Vicarious Surgical has a consensus target price of $7.00, suggesting a potential upside of 614.29%. Given Vicarious Surgical’s higher possible upside, analysts clearly believe Vicarious Surgical is more favorable than IDEXX Laboratories.

Volatility and Risk

IDEXX Laboratories has a beta of 1.58, meaning that its share price is 58% more volatile than the S&P 500. Comparatively, Vicarious Surgical has a beta of 1.49, meaning that its share price is 49% more volatile than the S&P 500.

Earnings and Valuation

This table compares IDEXX Laboratories and Vicarious Surgical”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IDEXX Laboratories	$4.30 billion	10.41	$1.06 billion	$13.58	41.83
Vicarious Surgical	N/A	N/A	-$63.22 million	($6.69)	-0.15

IDEXX Laboratories has higher revenue and earnings than Vicarious Surgical. Vicarious Surgical is trading at a lower price-to-earnings ratio than IDEXX Laboratories, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares IDEXX Laboratories and Vicarious Surgical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
IDEXX Laboratories	24.63%	70.87%	32.56%
Vicarious Surgical	N/A	-184.13%	-112.50%

Insider and Institutional Ownership

87.8% of IDEXX Laboratories shares are owned by institutional investors. Comparatively, 47.3% of Vicarious Surgical shares are owned by institutional investors. 0.8% of IDEXX Laboratories shares are owned by company insiders. Comparatively, 9.5% of Vicarious Surgical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

IDEXX Laboratories beats Vicarious Surgical on 11 of the 13 factors compared between the two stocks.

About IDEXX Laboratories

IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. Additionally, the company offers human medical point-of-care products and laboratory diagnostics services. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

About Vicarious Surgical

Vicarious Surgical Inc. operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.